An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren’t conclusive

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.



Source link

About The Author

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top